n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahi, M; Miyoshi, E; Otsu, K; Suzuki, K; Takeda, T; Taniguchi, N; Yokoe, S | 1 |
1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
Topics: Acetylglucosamine; Acylation; Animals; beta-N-Acetylhexosaminidases; Blotting, Western; Calcium; Calcium-Binding Proteins; Catecholamines; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; HeLa Cells; Humans; Immunoprecipitation; Male; Mutagenesis, Site-Directed; Mutation; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; Oximes; Phenylcarbamates; Phosphorylation; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2010 |